Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Gillessen S, Attard G, Beer T, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow R, Chi K, Clarke N, Davis I, de Bono J, Drake C, Duran I, Eeles R, Efstathiou E, Evans C, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano C, Hofman M, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli R, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans A, Morris M, Mottet N, Mrabti H, Murphy D, Murthy V, Oh W, Ost P, O'Sullivan J, Padhani A, Parker C, Poon D, Pritchard C, Reiter R, Roach M, Rubin M, Ryan C, Saad F, Sade J, Sartor O, Scher H, Shore N, Small E, Smith M, Soule H, Sternberg C, Steuber T, Suzuki H, Sweeney C, Sydes M, Taplin M, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology 2020, 77: 508-547. PMID: 32001144, DOI: 10.1016/j.eururo.2020.01.012.Peer-Reviewed Original ResearchConceptsAdvanced Prostate Cancer Consensus ConferenceAdvanced prostate cancerProstate Cancer Consensus ConferenceCastration-resistant prostate cancerProstate cancer expertsProstate cancerConsensus questionsManagement of advanced prostate cancerMetastatic castration-resistant prostate cancerNonmetastatic castration-resistant prostate cancerInternational prostate cancer expertsAdvanced prostate cancer treatmentCancer expertsEffects of hormone therapyConsensus conferenceAdverse effects of hormone therapyLocally advanced diseaseProstate cancer managementLevel 1 evidenceProstate cancer treatmentManagement of patientsPatient-specific factorsClinical trial enrollmentMultidisciplinary decision makingBiochemical recurrence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply